Skip to content

TO · HEXO.TO · DRUG MANUFACTURERS - SPECIALTY & GENERIC

HEXO Corp.

$0.88as of 2026-11-21 · Mkt cap 38.72M

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Healthcare · Drug Manufacturers - Specialty & Generic Gatineau, QC hexocorp.com

How the business is doing

Fiscal 2014–2022, USD

Revenue
$191.1M+115.6% 5y CAGRd
20142022
Net income
-$-1.07B
20142022
Free cash flow
-$-151.38M
20142022
Total equity
$313.7M+57.4% 5y CAGRd
20142022

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Financials

Statements by fiscal year

USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About HEXO Corp.

        HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. HEXO Corp. has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada.

        CEO
        Charlie Bowman
        Employees
        0
        Beta
        2.13

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.